US2012283203A1PendingUtilityA1
Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
Individually held — no corporate assignee on recordPriority: Jul 29, 2004Filed: Apr 30, 2012Published: Nov 8, 2012
Est. expiryJul 29, 2024(expired)· nominal 20-yr term from priority
A61P 5/10A61P 3/08A61P 3/06A61P 9/10A61P 3/10A61K 31/57A61K 31/7048A61P 3/04A61P 3/00A61K 31/353
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process of enhancing insulin excretion in a subject includes administering to the subject a polyphenol active ingredient. The polyphenol active ingredient is a purified cyanidin-3-glycoside alone or purified cyanidin alone. The pharmaceutically acceptable carrier is administered with the polyphenol active ingredient.
Claims
exact text as granted — not AI-modified1 . A method for weight loss administering to a mammalian subject comprising a mixture of purified anthocyanins alone or in combination with purified anthocyanidins to induce weight loss in said subject.
2 . The method of claim 1 wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins is cyanidin-3-glycoside alone.
3 . The process of claim 1 wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins is cyanidin alone.
4 . The process of claim 1 wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins is administered at a daily dosage of from 0.1 to 100 milligrams per kilogram of body weight of the subject.
5 . The process of claim 1 wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins with administered with a pharmaceutically acceptable carrier, said wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins and said pharmaceutically acceptable carrier both being essentially free of sugars.Join the waitlist — get patent alerts
Track US2012283203A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.